$9 Million Modification: Dakota Drug’s Continued Commitment to Military Healthcare

Dakota Drug Inc.,* Anoka, Minnesota, has been awarded an estimated $9,085,198 modification (P00018) extending the third two-year six-month option period of a two-year six-month base contract (SPE2DX-15-D-8000) with three two-year six-month option periods for prime vendor pharmaceutical and pharmaceutical-related products and support. This is a firm-fixed-price, requirements contract. Locations of performance are North Dakota and South Dakota, with a Nov. 12, 2025, performance completion date. Type of appropriation is fiscal 2025 through 2026 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.